Palmitoylethanolamide is much used in the Netherlands in pet animals, mostly as 400 mg capsules pure PEA. in 2016 2 companies intensified their efforts to bring more PEA products to the market of pet animals:
Premune and Innovet Italia announced that they have expanded their collaboration by signing an exclusive licensing agreement for six additional products, targeting three key areas in companion animal well-being. The extended product range now includes Retopix® Spray, Retopix® Fluid, and Retopix® Oto (skin care), Normalia® (support of gut function) and Oculvet® Wipes and Oculvet® Drops (eye care).
The companies initiated a collaboration in August 2015 with the exclusive licensing agreement for Redonyl® Ultra, a nutritional supplement for support of normal skin function in cats and dogs based on PEA-um® (ultramicronized palmitoylethanolamide). Palmitoylethanolamide is a naturally occurring compound produced on demand by the body in response to inflammation and pain. Retopix®, Normalia® and Oculvet® all contain either PEA-um® or Adelmidrol, an analogue of PEA formulated specifically for topical administration.
The expanded collaboration gives Premune exclusive marketing rights for key European countries, with the option to expand to other geographies including North America. This brings the current Premune portfolio to seven products, all of which will be launched during 2016.